Evidence map›Paper›PMID 38376841›Full record

Observational studyJAMA network open2024

Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young Adults.

Esmée Verburgt, Nina A Hilkens, Merel S Ekker, Mijntje M I Schellekens, Esther M Boot, Maikel H M Immens, Mayte E van Alebeek, Paul J A M Brouwers, Renate M Arntz, Gert W van Dijk and 19 more

Registry-linked trialOpen access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07171242 (Shanghai Prospective Registry Study of Ischemic Stroke), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07171242 recruitingnot on this map

Shanghai Prospective Registry Study of Ischemic Stroke

TypeobservationalSponsorQiang DongRan2024 to 2029Enrolled15,000ConditionsIschemic Stroke
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Young stroke: An update on epidemiology, emerging risk factors, and future research directions.International journal of stroke : official journal of the International Stroke Society · 2026
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 17 institutions in 1 country.

Esmée VerburgtDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Nina A HilkensDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Merel S EkkerDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Mijntje M I SchellekensDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Esther M BootDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Maikel H M ImmensDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Mayte E van AlebeekDepartment of Neurology, Gelre Hospital, Apeldoorn, the Netherlands.
Paul J A M BrouwersDepartment of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
Renate M ArntzDepartment of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
Gert W van DijkDepartment of Neurology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.
Rob A R GonsDepartment of Neurology, Catharina Hospital, Eindhoven, the Netherlands.
Inge W M van UdenDepartment of Neurology, Catharina Hospital, Eindhoven, the Netherlands.
Tom den HeijerDepartment of Neurology, Sint Franciscus Gasthuis Hospital, Rotterdam, the Netherlands.
Julia H van TuijlDepartment of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Karlijn F de LaatDepartment of Neurology, Haga Hospital, The Hague, the Netherlands.
Anouk G W van NordenDepartment of Neurology, Amphia Hospital, Breda, the Netherlands.
Sarah E VermeerDepartment of Neurology, Rijnstate Hospital, Arnhem, the Netherlands.
Marian S G van ZagtenDepartment of Neurology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
Robert J van OostenbruggeDepartment of Neurology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Marieke J H WermerDepartment of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.
Paul J NederkoornDepartment of Neurology, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
Henk KerkhoffDepartment Neurology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Fergus A RooyerDepartment of Neurology, Zuyderland Hospital, Sittard-Geleen, the Netherlands.
Frank G van RooijMedical Centre Leeuwarden, Department of Neurology, Leeuwarden, the Netherlands.
Ido R van den WijngaardDepartment of Neurology, Haaglanden Medical Centre, The Hague, the Netherlands.
Tim J F Ten CateDepartment of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Anil M TuladharDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Frank-Erik de LeeuwDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Jamie I VerhoevenDonders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Radboud University Nijmegen · NLMedisch Spectrum Twente · NLAlbert Schweitzer Ziekenhuis · NLAmphia Ziekenhuis · NLCanisius-Wilhelmina Ziekenhuis · NLElisabeth-TweeSteden Ziekenhuis · NLGelre Hospitals · NLHaga Hospital · NLJeroen Bosch Ziekenhuis · NLMaastricht University Medical Centre · NLMedisch Centrum Haaglanden · NLMedisch Centrum Leeuwarden · NLRijnstate Hospital · NLSint Franciscus Gasthuis · NLUniversity Medical Center Groningen · NLUniversity of Amsterdam · NLZuyderland Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Cause of ischemic stroke in young people is highly variable; however, the risk of recurrence is often presented with all subtypes of stroke grouped together in classification systems such as the Trial of ORG (danaparoid sodium [Orgaran]) 10172 in Acute Stroke Treatment (TOAST) criteria, which limits the ability to individually inform young patients with stroke about their risk of recurrence. Objective: To determine the short-term and long-term risk of recurrent vascular events after ischemic stroke at a young age by stroke cause and to identify factors associated with recurrence. Design, Setting, and Participants: This cohort study used data from the Observational Dutch Young Symptomatic Stroke Study, a prospective, multicenter, hospital-based cohort study, conducted at 17 hospitals in the Netherlands between 2013 and 2021. Eligible participants included 30-day survivors of an initial, neuroimaging-proven ischemic stroke (aged 18-49 years). Data analysis was conducted from June to July 2023. Exposure: Diagnosis of a first-ever, ischemic stroke via neuroimaging. Main Outcome and Measures: The primary outcome was short-term (within 6 months) and long-term (within 5 years) recurrence risk of any vascular event, defined as fatal or nonfatal recurrent ischemic stroke, transient ischemic attack, myocardial infarction, and revascularization procedure. Predefined characteristics were chosen to identify factors associated with risk of recurrence (cause of stroke, age, sex, stroke severity, and cardiovascular health factors). Results: A total of 1216 patients (median [IQR] age, 44.2 [38.4-47.7] years; 632 male [52.0%]; 584 female [48.0%]) were included, with a median (IQR) follow-up of 4.3 (2.6-6.0) years. The 6-month risk of any recurrent ischemic event was 6.7% (95% CI, 5.3%-8.1%), and the 5-year risk was 12.2% (95% CI, 10.2%-14.2%)The short-term risk was highest for patients with cervical artery dissections (13.2%; 95% CI, 7.6%-18.7%). Other factors associated with a recurrent short-term event were atherothrombotic stroke, rare causes of stroke, and hypertension. The long-term cumulative risk was highest for patients with atherothrombotic stroke (22.7%; 95% CI, 10.6%-34.7%) and lowest for patients with cryptogenic stroke (5.8%; 95% CI, 3.0%-8.5%). Cardioembolic stroke was associated with a recurrent long-term event, as were diabetes and alcohol abuse. Conclusions and Relevance: The findings of this cohort study of 1216 patients with an ischemic stroke at a young age suggest that the risk of recurrent vascular events was high and varied by cause of stroke both for short-term and long-term follow-up, including causes that remained concealed when combined into 1 category in the routinely used TOAST criteria. This knowledge will allow for more personalized counseling of young patients with stroke.

Indexed as

Ischemic Attack, TransientIschemic StrokeStrokeAdolescentAdultCohort StudiesFemaleHumansMaleProspective StudiesYoung Adult

Identifiers

PMID38376841
PMCPMC10879951
OpenAlexW4391954327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.